The following report was received via fax:
On May 4, 2011 a patient underwent a Y-90 therapy procedure. Two doses were to be administered to the right lobe of the patient's liver. The first dose was terminated when stasis was achieved. The second dose was terminated because of patient pain after 48% of the dose had been delivered. The pain during the second dose was considered most likely due to embolization. The licensee notified VDH (Virginia Department of Health) and requested guidance on whether the circumstances could be due to patient intervention. It was determined by VDH to be a medical event and not excepted because of patient intervention. A conference call was held with the licensee on June 10th and a written report submitted to VDH. The licensee indicated written directives, patient preparation, and pain control methods would be reviewed.
A Medical Event may indicate potential problems in a medical facility's use of radioactive materials. It does not necessarily result in harm to the patient.